A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma

Journal of Dermatological Treatment

Volumn 24, Issue 1, 2013, Pages 70-74

  Avci, Oktay ^a   Tanyildizi, Taner ^a   Kusku, Ergun ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Clarithromycin; Erythrasma; Erythromycin; Fusidic acid

Indexed keywords

CLARITHROMYCIN; ERYTHROMYCIN; FUSIDIC ACID; PLACEBO;

ABDOMINAL CRAMP; ADULT; AGED; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHRASMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; ERYTHRASMA; ERYTHROMYCIN; FEMALE; FUSIDIC ACID; HUMANS; MALE; MIDDLE AGED; SKIN CREAM; SKIN DISEASES, BACTERIAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872345807     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2011.594870     Document Type: Article

References (18)

1. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Bacterial diseases. In: Dermatology. Berlin: Springer-Verlag; .2000. p. 166-167.
2. Asawanonda P, Taylor CR. Wood's light in dermatology. Int J Dermatol. 1999;38:801-807.
3. Dellion S, Morel P, Vignon-Pennamen D, Felten A. Erythrasma owing to an unusual pathogen. Arch Dermatol. 1996;132:716-717.
4. Blaise G, Nikkels AF, Hermanns-Lê T, Nikkels-Tassoudji N, Piérard GE. Corynebacterium-associated skin infections. Int J Dermatol. 2008;47:884-890.
5. Morales-Trujillo ML, Arenas R, Arroyo S. Interdigital erythrasma: clinical, epidemiologic, and microbiologic findings. Actas Dermosifiliogr. 2008;99:469-473.
6. Maleki M, Fata A. Evaluation of wood s light and direct smear for diagnosis of pityriasis versicolor and erythrasma. Saudi Med J. 2005;26:1483-1484.
7. Karakatsanis G, Vakirlis E, Kastoridou C, Devliotou-Panagiotidou D. Coexistence of pityriasis versicolor and erythrasma. Mycoses. 2004;47:343-345.
8. Wigger-Alberti W, Elsner P. Fluorescence with Wood's light. Current applications in dermatologic diagnosis, therapy follow-up and prevention. Hautarzt. 1997;48:523-527.
9. Holdiness MR. Management of cutaneous erythrasma. Drugs. 2002;62:1131-1141.
10. Holdiness MR. Erythrasma and common bacterial skin infections. Am Fam Physician. 2003;67:254.
11. Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol. 1998;139(Suppl 53):37-40.
12. Spelman D. Fusidic acid in skin and soft tissue infections. Int J Antimicrob Agents. 1999;12(Suppl 2):S59-S66.
13. Massone L, Pestarino A, Borghi S, Bianchi W, Salvini P. Treatment of erythrasma with 1% bifonazole cream. Clin Ter. 1987;123:105-109.
14. Haman K, Thorn P. Systemic or local treatment of erythrasma? A comparison between erythromycin tablets and fucidin cream in general practice. Scand J Prim Health Care. 1991;9:35-39.
15. MacMillan AL, Sarkany I. Specific topical therapy for erythrasma. Br J Dermatol. 1970;82:507-509.
16. Wharton JR, Wilson PL, Kincannon JM. Erythrasma treated with single-dose clarithromycin. Arch Dermatol. 1998;134: 671-672.
17. Goldstein EJ, Hunt Gerardo S, Hudspeth M, Merriam CV. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin,andeightotherantimicrobialagents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans. Antimicrob Agents Chemother. 1998;42:1127-1132.
18. De Briel D, Couderc F, Riegel P, Jehl F, Minck R. High-performance liquid chromatography of corynomycolic acids as a tool in identification of Corynebacterum species and related organisms. J Clin Microbiol. 1992;30:1407-1417.